The GBS CIDP Foundation International is pleased to announce a competition for the first Benson Clinical Research Fellowship. The aim of the scheme is to provide funds (up to $150k per year for three years) to enable clinicians or non-clinical scientists in training or having recently completed training to engage in a substantial research project in the field of inflammatory neuropathy at a centre or centres of excellence. Preference will be given to candidates who intend to pursue a long-term career in this field. Applicants should obtain application forms from Camille Yee at Camille.Yee@gbs-cidp.org. Completed forms should be submitted by email to Camille Yee at Camille.Yee@gbs-cidp.org by midnight EST Friday, June 20, Short-listed candidates may be required to make a presentation to the 13th International Symposium of the GBS CIDP Foundation International Friday, October 31, 2014 – Sunday, November 2, 2014, at Walt Disney World, Lake Buena Vista, Florida.
Centers of ExcellenceExpert diagnosis & management of inflammatory neuropathies is critical to our patients. This is what our medical advisory board members had in mind when setting up the new Centers of Excellence program. A year later, we continue to add healthcare facilities providing exactly that.
View Centers of Excellence
Connect With Us
TOPICS OF INTEREST
October 31st - November 2nd, 2014 at Walt Disney World Coronado Springs Resort and Convention Center in Lake Buena Vista, Florida. Learn More >>
The GBS CIDP Foundation International is pleased to announce a competition for the first Benson Clinical Research Fellowship.
Recently, one of the physicians on the GBS/CIDP Foundation Medical Advisory Board saw a man who carried the diagnosis of CIDP for 2 years. More >>
Richard J. Barohn, MD, Professor and Chair Department of Neurology at the University of Kansas Medical Center, and a member of the GBS/CIDP Foundation International Medical Advisory Board gave a presentation to the Harris County Neurological Society in November.
CSL Behring is currently recruiting CIDP patients for a clinical trial. More>>>